12.8
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
View the full transcript and gain access to JoVE Core videos
Q1: What is the principle of superposition in multiple-dose pharmacokinetics?
The principle of superposition predicts plasma drug concentration following multiple doses by assuming each dose behaves independently and the drug's elimination follows first-order kinetics. It allows estimation of concentration-time curves from consecutive doses based on single-dose data, provided pharmacokinetics remain constant over the dosing interval and early doses do not affect subsequent dose kinetics.
Q2: How does the dosing interval affect drug accumulation in the body?
The fraction of drug remaining in the body decreases exponentially as the dosing interval increases. Longer intervals between doses result in lower drug levels because more time allows for elimination. This relationship is critical for optimizing dosing schedules to maintain therapeutic drug levels while minimizing toxicity risk.
Q3: What assumptions must be met for the superposition principle to apply accurately?
The superposition principle requires that drug elimination follows first-order kinetics, pharmacokinetics remain constant across dosing intervals, and early doses do not alter the kinetics of subsequent doses. However, adjustments become necessary when drug interactions or changes in enzyme activity affect elimination rates, requiring modified calculations.
Q4: Why is calculating drug accumulation important in clinical practice?
Calculating drug accumulation is vital for achieving therapeutic efficacy while avoiding toxicity in multiple-dose regimens. Accurate predictions of plasma drug concentrations enable optimization of dosing schedules, particularly in chronic disease management and prolonged antibiotic therapy, ensuring safe and effective drug administration.
Q5: What does the fraction of drug remaining in the body represent?
The fraction of drug remaining in the body is the ratio of the amount of drug still present in the body to the initial dose administered. This fraction decreases exponentially with each dosing interval, indicating how much of the previous dose remains when the next dose is given, directly influencing cumulative drug levels.
Q6: How do drug interactions affect multiple-dose pharmacokinetic calculations?
Drug interactions and changes in enzyme activity can alter elimination rates, violating the superposition principle's assumption that pharmacokinetics remain constant. When these factors are present, adjustments to standard calculations become necessary to accurately predict drug accumulation and maintain therapeutic drug levels.
Q7: What role does the elimination constant play in predicting drug accumulation?
The elimination constant determines the rate at which drug is removed from the body and is essential for calculating the fraction of drug remaining after each dosing interval. Combined with the dosing interval, it enables prediction of plasma concentrations and helps determine appropriate dosing schedules for maintaining therapeutic efficacy.